This study reports the epidemiological characteristics of hospitalized cases of influenza A(H1N1)pdm09 infection analyzed on the basis of surveillance data collected from July 24, 2009, the date on which the hospital-based surveillance of influenza cases was implemented in Japan, to September 5, 2010. During the study period, 13,581 confirmed cases were reported. Among those cases with information regarding the reason for hospitalization, 39z were admitted to hospitals for non-therapeutic purposes such as medical observation and laboratory testing. The overall hospitalization rate was 5.8 cases per 100,000 population when cases hospitalized for non-therapeutic purposes were excluded. While those aged under 20 years accounted for over 85z of hospitalized cases, the largest proportion of fatal cases was observed in those aged over 65 years. The overall case fatality rate for all hospitalized cases was 1.5z. The year-round surveillance for hospitalized influenza-like illness cases was launched in 2011, and it was expected that this surveillance system could add value by monitoring changes in the epidemiological characteristics of hospitalized cases of seasonal influenza.
INTRODUCTION
After being reported in Mexico, the United States, and Canada, influenza A(H1N1)pdm09 rapidly spread throughout the world. In response to the emerging influenza virus, the Ministry of Health, Labour and Welfare (MHLW) of Japan conducted case-based surveillance of influenza A(H1N1)pdm09 from April 29 to July 23, 2009 , in addition to utilizing the existing sentinel surveillance system of influenza-like-illness (ILI) and implementing several other mitigation strategies. The first domestic outbreaks were reported on May 16, 2009 in secondary schools in the Hyogo and Osaka prefectures in western Japan. Both the prefectural and municipal governments responded by implementing a program of extensive school closures to mitigate transmission, resulting in the temporary closure of approximately 4,000 schools, corresponding to approximately 1.5 million students. Implementation of this program appeared to temporarily result in the interruption of influenza A(H1N1)pdm09 virus transmission (1) . Although investigations of these early outbreaks in Japan revealed that all cases observed in schools and the community were relatively mild, several reports from other countries during the early phase of the epidemic indicated that persons who were at a high risk for severe outcomes because of seasonal influenza infection, were similarly at an increased risk for severe outcomes from influenza A(H1N1)pdm09 infection (2) (3) (4) .
On July 24, 2009 , MHLW launched a nationwide program for the surveillance of hospitalized cases of influenza A(H1N1)pdm09. The goals of this program were to collect data regarding the clinical features of severe cases and to monitor changes in the severity of the disease and virological characteristics of influenza A(H1N1)pdm09. The aim of the present study was to clarify the characteristics of hospitalized cases of A(H1N1)pdm09 infection on the basis of analyses of the surveillance data collected during the 2009/2010 season.
MATERIALS AND METHODS
Data sources: (i) Sentinel ILI surveillance: Approximately 5,000 nationwide sentinel medical facilities, which were designated by each prefecture, were required to report the weekly number of ILI cases aggregated by age group to local public health centers, which were then aggregated at the national level, both at MHLW and the National Institute of Infectious Diseases (NIID), Tokyo, Japan. Every year since 1987, the year in which the year-round sentinel surveillance of ILI was implemented, the beginning and the ending of the influenza season were announced when the number of ILI cases per sentinel site exceeded 1.0 for 2 consecutive weeks and when the number decreased below 1.0 for 2 consecutive weeks, respectively. A case definition for the diagnosis of ILI was as follows: the patient either (i) experienced sudden onset of high fever with upper respiratory and systemic symptoms or (ii) received a July 24, 2009 , the end of the 30th week in 2009, case-based surveillance was terminated. Subsequently, influenza A(H1N1)pdm09 has been monitored through the sentinel ILI surveillance system. (ii) Hospital-based case-based influenza A(H1N1) pdm09 surveillance: Starting on July 24, 2009, physicians were requested to report hospitalized ILI cases other than those with influenza virus type B infection via the interim National Epidemiological Surveillance of Infectious Diseases (iNESID) in Japan, a web-based data collection system. For each case, physicians were requested to report the age, sex, underlying medical condition(s), relevant dates (onset, admission, and discharge), reason for admission, medications prescribed (including antivirals, herbal medications, or others), and period of medication administration. Physicians were also requested to report whether each case was characterized by 1 or more of the following indicators for severity assessment: (i) presence of pneumonia, (ii) administration of oxygen, (iii) use of a mechanical ventilator, (iv) presence of encephalopathy, (v) admission to the intensive care unit (ICU), and/or (vi) use of extracorporeal membrane oxygenation. Underlying medical conditions were categorized into 1 of the following 9 categories according to disease characteristics: (i) pulmonary disease, including asthma; (ii) cardiovascular disease; (iii) renal disease; (iv) liver disease; (v) neurological disease; (vi) diabetes mellitus (DM); (vii) immunosuppressive condition; (viii) obesity; or (ix) pregnancy. The originally reported reason for hospitalization for each case was further classified into 1 of the following 5 categories: (i) severe condition, (ii) treatment primarily for underlying disease(s), (iii) observation, (iv) other reason with or without specified report, or (v) unknown diagnosis and for proper diagnosis. These 5 categories were recategorized into 11 categories as shown in Table 1 : (i) non-therapeutic purpose, (ii) severe condition, (iii) acute dermato/mucosal/hemor-rhagic syndrome, (iv) acute respiratory syndrome, (v) acute gastrointestinal syndrome, (vi) acute neurological syndrome, (vii) acute non-specific syndrome, (viii) pregnancy, (ix) acute cardiac condition (e.g. myocarditis), (x) dead on arrival, and (xi) unknown/no answer. The category designated``non-therapeutic purposes'' included hospitalization without any medical therapy, for observation purposes only, and/or for laboratory/diagnostic testing, or hospitalization for patient isolation, the latter of which was recommended in the original pandemic preparedness plan implemented in 2008 in Japan. Most prefectures and local governments abandoned the policy of isolation on the basis of the results of investigations in Hyogo and Osaka in May 2009 because it was revealed that influenza A(H1N1)pdm09 cases did not exhibit significantly more severe clinical features. However, several local governments and/or physicians continued following the initial pandemic influenza response guidelines published by MHLW, even at the time when hospitalized surveillance began in late July 2009. Hospitalized cases were dichotomized by reason for hospitalization (i.e., non-therapeutic vs. therapeutic) and compared by their specific characteristics. Similar comparisons were made between non-fatal and fatal cases. Population estimates for 2009 made by MHLW (5) were used to compute the hospitalization rate. For statistical analysis, univariate analysis was performed using SAS Statistical Analysis Software version 9.2 for Windows (Cary, NC, USA).
RESULTS
Trends in ILI and hospitalized cases: Influenza activity reached an epidemic-level (i.e., the number of ILI cases per sentinel ＞1.0) at week 33, and the number of cases peaked at week 48 in 2009 (http://idsc.nih.go.jp/ iasr/31/367/tpc367.html). The highest number of hospitalized cases was reported in weeks 46 and 47 ( Fig. 1 ). The number of ILI cases per sentinel decreased below 1.0 in week 8 of 2010.
Overview of hospitalized patients during the study period: According to the data reported to iNESID, 17,634 ILI cases were hospitalized from July 24, 2009 (week 30) to September 5, 2010 (week 35) ( Fig. 2 ). Of these, 13,749 were tested using the reverse transcription polymerase chain reaction for influenza virus. Of these, 13,581 (98.77z), 3 (0.02z), and 3 (0.02z) cases tested positive for A(H1N1)pdm09, H3N2, and influenza B, respectively, while 164 (1.19z) tested negative for any influenza virus.
Hospitalization rate: The overall hospitalization rate per 100,000 population was 10.7 (95z confidence interval [CI] 10.5-10.8) during the study period. The highest hospitalization rate was observed in those aged under 5 years (58.6/100,000 population, 95z CI 56.5-60.6), followed by those aged 5-19 years (48.8/100,000 population, 95z CI 47.7-49.8) and those aged 65 years and older (2.0/100,000 population, 95z CI 1.8-2.2). The lowest hospitalization rate was observed in those aged 20-64 years (1.6/100,000 population, 95z CI 1.5-1.7). Focusing only on the patients who were hospitalized for treatment purposes (n ＝ 7,427), the overall hospitalization rate was 5.8 per 100,000 population during the study period. Characteristics of hospitalized cases by reason for hospitalization: The reasons for hospitalization were available for 12,748 cases ( Table 2 ). Of these, cases hospitalized for therapeutic purposes accounted for 54.7z (n ＝ 7,427). Cases hospitalized for non-therapeutic purposes consistently accounted for approximately 40z during the study period (median 42.8z, interquartile range [IQR] 40.8z-46.1z, range 30.0z-52.8z). Men accounted for over 60z; however, the difference be-tween the sexes did not reach the level of statistical significance ( P ＝ 0.07). The median age of all 13,581 cases was 7 years (IQR 5-11 years, range 0-102 years), and the highest number of cases was observed in those aged 5-19 years. Overall, 11,055 cases (86.7z) involved patients aged under 20 years. The age distribution of the non-therapeutic group was significantly different from that of the therapeutic group ( P  0.01), with under 5 years and equal to and older than 65 years of age tend- ing to be observed more frequently in the non-therapeutic group. With Regard to underlying medical conditions, 5,150 (40.3z) cases involved at least 1 underlying condition, and pulmonary disease was the most frequently reported (overall proportion: 23.2z). The proportion of cases with renal diseases in the non-therapeutic group was significantly higher than that in the other groups (P ＜ 0.01). With regard to the vaccination status, approximately 50z of the patients were vaccinated against neither A(H1N1)pdm09 nor seasonal influenza. More specifically, only 2.0z of the patients had been vaccinated against A(H1N1)pdm09. In addition, the vaccination status significantly differed be-tween the 2 groups ( P ＜ 0.01, Table 2 ), and cases admitted for therapeutic purposes had a greater tendency to have received either seasonal or A(H1N1)pdm09 influenza vaccines. With regard to medications, antivirals (oseltamivir or zanamivir) were administered to 86.9z (n ＝ 4,621) of the patients despite their hospitalization for non-therapeutic purposes (e.g., observation).
Although severe conditions were reported more often from cases admitted for therapeutic reasons, 24z (n ＝ 883) of patients who were not initially considered to require therapy developed pneumonia and 1z (n ＝ 66) required mechanical ventilation. In total, 51 cases (1.0z) in the non-therapeutic group were reported to Hospitalized A(H1N1)pdm09 Cases, 2009-2010, Japan have developed encephalopathy. In addition, 26 of the 244 patients who were admitted for non-therapeutic reasons and not prescribed antivirals presented with pneumonia, and 1 presented with encephalopathy.
Characteristics of non-fatal and fatal hospitalized cases: Epidemiological characteristics between non-fatal and fatal cases were examined and compared. The outcome of hospitalized cases was available for 12,846 patients. Among these, 191 fatal cases were reported through the iNESID system during the study period, yielding an overall mortality rate of 0.14 per 100,000 population. The overall case fatality rate (CFR) of all hospitalized cases was 1.5z (95z CI 1.3-1.7z) for the study period, with the highest rate being observed in those aged 65 years and older (9.0z, 95z CI 6.6z-11.4z), followed by those aged 20-64 years (8.8z, 95z CI 7.2z-10.5z). CFR was 1.0z among cases involving those aged under 20 years 0.7z (95z CI 0.4z-1.0z) and 0.3z (95z CI 0.2z-0.4z) for those aged under 5 years and those aged 5-19 years, respectively.
While the most frequent underlying disease among fatal cases was pulmonary disease, no statistically significant difference was detected in comparison with non-fatal cases ( Table 3) . Other underlying conditions, such as DM, neurological disease, and cardiovascular disease were found in a greater proportion of the fatal cases (P ＜ 0.01) ( Table 3) . Over half of all fatal cases had not been vaccinated against either the A(H1N1) pdm09 or seasonal influenza viruses. Antivirals had been prescribed to 159 patients (83.2z) among fatal cases and to 10,925 patients (86.3z) among non-fatal cases ( Table 3 ). The prescription of antivirals other than zanamivir was observed more often among fatal cases. Severe conditions such as pneumonia and encephalopathy were more frequently reported among fatal cases ( P ＜ 0.01). Among the 94 fatal cases that had developed pneumonia, 61 (65z) required mechanical ventilation, and 4 (80z) of the 5 cases that had developed both pneumonia and encephalopathy required it as well. The median number of days from onset to consultation for fatal cases was 1 (IQR 0-2 days, range 0-17 days). Unfortunately, the median number of days from onset to consultation among the non-fatal cases could not be calculated because the onset date was reported only for 1 case. Eight of the fatal cases had been hospitalized for non-therapeutic reasons such as medical observation. One of these patients was a 5-yearold girl with a congenital disorder, while the other 7 were adults aged over 40 years with underlying medical conditions. Of these, 4 had multiple underlying diseases.
DISCUSSION
The analyses described in this report pertaining to the referenced surveillance data indicated that the overall crude hospitalization rate for influenza A(H1N1)pdm09 infection was 10.7 per 100,000 population in Japan during the study period. This rate is similar to those found in Mexico, Chile, and Brazil and 50z of the rate observed in Australia, the Unites States, and Argentina during the same period (6, 7) . Consistent with the results described in other reports, over 80z of hospitalized cases in the present study were young (＜20 years) (4, (7) (8) (9) (10) (11) 35) . It is interesting to note that the results from several studies have indicated that the elderly were not disproportionately affected by the virus, perhaps because of cross immunity to A(H1N1)pdm09 in this population (12) (13) (14) . In fact, a survey of antibody prevalence in Japan conducted during July-September 2009 showed a higher prevalence of A(H1N1)pdm09 antibodies in those aged over 80 years (11z-44z) than in other age groups (15) . Given that younger age groups were the most affected population during the survey period in Japan, the high prevalence of A(H1N1)pdm09 antibody among the elderly may be attributable to cross reaction with antibodies to previous seasonal influenza viruses. Although the younger age group occupied a large proportion of hospitalized cases, patients aged 20 years and older constituted more than 80z of fatal cases, with those aged 50 years and older accounting for nearly half of the deceased. CFR in those aged 20 years and older was significantly higher than that in those aged under 20 years. These results were consistent with the results from previous reports and reaffirmed that A(H1N1)pdm09 virus infection led to high morbidity in the young population and a high CFR in the elderly population (4, (7) (8) (9) (10) (11) .
In Japan, it has been observed that many patients are admitted to hospitals for non-therapeutic reasons, including assessments of clinical progress, even when medication and/or fluid transfusion are not prescribed. The proportion of patients hospitalized for non-therapeutic reasons during this study period (40z-45z) was a finding contrary to our assumption that more cases would be admitted for non-therapeutic reasons (e.g., isolation, laboratory testing) during the earlier stages of the pandemic. While the surveillance reporting form did not differentiate the category for non-therapeutic hospitalization, we assumed that a majority of such cases were admitted for medical observation because isolation was not considered as a practical mitigation measure on the basis of experience from the first domestic outbreak. However, because there are no data available regarding ILI patients who were hospitalized for medical observation in Japan, we cannot assess whether this finding is specific to the first season of the pandemic influenza or whether similar trends existed for seasonal influenza as well. When cases hospitalized for non-therapeutic reasons were excluded, the overall hospitalization rate was 5.8 per 100,000 population. A comparison between cases hospitalized for therapeutic vs. non-therapeutic reasons showed that patients aged under 5 and equal to or older than 65 years were more frequently observed in the non-therapeutic group.
Those aged under 5 years are considered to be vulnerable to severe outcomes and to have the highest mortality among the population aged under 20 in Japan (16) . Therefore, parents and clinicians likely became more cautious when they displayed ILI symptoms and, consequently, more cases remained in the hospital for medical observation. Similar reasons may apply to those aged 65 years and older. First, with regard to the proportion of those with an underlying medical condition, only renal disease was more frequent in the non-therapeutic group. This may have been because of the fact that the first 2 fatal cases of influenza A(H1N1)pdm09 infection in Japan involved patients with chronic renal failure requiring dialysis (17, 18) . Such reports may have served as a warning to patients, the public, and clinicians that those with chronic renal failure may be at an increased risk of developing serious outcomes and may have increased hospitalization rates. Second, cases admitted for therapeutic reasons were more likely to have been vaccinated for seasonal influenza viruses. It has been reported that seasonal trivalent inactivated vaccine provided partial protection against influenza A(H1N1)pdm09 (19, 20) , although results from another study did not detect this protective effect (21) . In the present study, we could not draw any conclusions regarding the association between vaccination and hospitalization because this comparison was not adjusted by age or underlying condition, and more importantly, the date of vaccination was not available. In addition, it is understandable that cases hospitalized for non-therapeutic reasons were significantly less likely to be administered antivirals. It is notable that among those who were hospitalized for non-therapeutic reasons and not administered antivirals, 26 cases were diagnosed as pneumonia and 1 case was diagnosed as encephalopathy. Antivirals were administered at similar proportions among non-fatal and fatal cases (86z and 83z, respectively). The results from studies conducted in Australia, China, and the US indicated similar proportions of antiviral administration among hospitalized patients (2, 22, 23, 36, 45) . Several studies have suggested that early treatment with neuraminidase inhibitors is beneficial for ILI patients and may reduce serious complications; however, the benefit of neuraminidase inhibitors remains controversial (2,22-35, 41,44,46) . Information pertaining to the date of ILI onset, complications, and the administration of antivirals, including whether antivirals were eventually administered when complications were diagnosed, may have better enabled us to compare and analyze associations between antiviral treatment and severe complications, including death. With regard to fatal cases, the overall CFR of hospitalized cases was 1.5z, which was remarkably low compared with CFR of 7z-11z reported from the US (3, 8) . As previously mentioned, however, approximately 40z of hospitalized cases had been admitted for non-therapeutic purposes. Although the US-based data did not address hospitalized cases admitted for non-therapeutic purposes, CFR in the present study calculated using only cases hospitalized for therapeutic reasons was 2.5z, approximately one-third that of the US. The reason for such a difference may be attributable to indications for hospitalization (i.e., larger denominator with less severe cases) and information bias (i.e., underreported fatal cases) or other artifacts. On the other hand, it may also be possible that the ease of medical accessibility in Japan, which allowed patients to be admitted for medical observation, contributed to a lower CFR. In fact, 17z (883/5,321) of the patients who were initially admitted to the hospital for non-therapeutic reasons were reported to develop pneumonia and 8 patients died. There may have been cases whose life-threatening deteriorations were detected early in the hospital, leading to the prevention of fatalities. Contrary to the results from many other studies (25, (33) (34) (35) , underlying pulmonary diseases were not significantly different between fatal and non-fatal cases. It should be noted, however, that the 1 overall category used to capture underlying pulmonary diseases may have been too crude to elucidate an association with death. More detailed pulmonary disease categories such as asthma and chronic obstructive pulmonary diseases may have been helpful in analyzing the association with death. With regard to the seasonal influenza vaccination status, our results did not indicate significant differences between non-fatal and fatal cases. However, our study was not suited to analyze the association between vaccination and fatality because of the lack of vaccination date data. In addition, other potential confounding factors were not considered in this analysis. Several studies have reported that pregnant women, particularly those in the third trimester, were at a higher risk of developing severe outcomes of influenza (25, (36) (37) (38) (39) (40) (41) (42) (43) (44) . Knowledge of these findings may have led gynecologists to be more willing to prescribe antivirals to pregnant women with ILI symptoms, leading to the 0z fatality rate among the 45 pregnant women in the present study. However, we did not have access to data regarding gestation periods; thus, we cannot know how many cases were in their third trimester.
This study had several limitations. First, there was an abundance of missing data. For example, height and weight were missed in almost all cases, preventing analyses such as a comparison of body mass index between fatal and non-fatal cases. Second, several items such as gestational age and the dates of vaccination and antiviral administration were not included in the reporting form, limiting the extent of our analysis. Third, the surveillance report did not indicate definitions or detailed descriptions for the underlying medical conditions and complications that were diagnosed during hospitalization. Therefore, we could not subcategorize chronic lung diseases or differentiate clinically and radiographically diagnosed pneumonia. It is possible that such crude measures may have diluted some results despite the existence of true associations. Fourth, data regarding temporality to better assess associations were lacking. For example, it was unclear whether pneumonia was diagnosed on the date of admission or later. Similarly, patients who died because of complications of pandemic influenza several weeks after hospitalization may not have been reported, thereby limiting the interpretation of low CFR. Finally, because these are surveillance data, under-reporting is expected to have occurred, and its extent and nature were not determined. Nevertheless, there was no obvious tendency regarding missing data and the factors that were compared between non-therapeutic vs. therapeutic cases and nonfatal vs. fatal cases. Therefore, results from these comparisons should still be considered as reliable.
In conclusion, young patients accounted for the majority of the hospitalized cases, while elderly patients displayed a high CFR. Approximately 40z of hospitalized cases were admitted for non-therapeutic reasons throughout the study period, and fatal cases were also observed among such cases. Because the program for the hospital-based surveillance for influenza and/or ILI was the first of its kind to have been implemented in Japan, comparisons of the clinical manifestations of A (H1N1)pdm09 virus infection cases and seasonal virus infection cases could not be conducted. Nevertheless, our findings provide a better understanding of the epidemiological characteristics of severe cases of influenza A(H1N1)pdm09 infection in Japan and contribute to the design of routine programs for hospital-based surveillance of influenza and ILI.
